Repositorio Dspace

Listar por autor "Rodríguez-Antiguedad, A"

Listar por autor "Rodríguez-Antiguedad, A"

Ordenar por:Orden:Resultados:

  • Consensus statement on the use of alemtuzumab in daily clinical practice in Spain 
    Meca-Lallana, J-E; Fernández-Prada, M; García-Vázquez, E; Moreno-Guillén, S; Otero-Romero, S; Rus-Hidalgo, M; Villar-Guimerans, L-M; Eichau-Madueno, S; Fernández-Fernández, O; Izquierdo-Ayuso, G; Álvarez-Cermeno, José-C; Arnal-García, C; Arroyo-González, R; Brieva-Ruiz, L; Calles-Hernández, C; García-Merino, A; González-Platas, M; Hernández-Pérez, M-A; Moral-Torres, E; Olascoaga-Urtaza, J; Oliva-Nacarino, P; Oreja-Guevara, C; Ortiz-Castillo, R; Oterino, A; Prieto-González, J-M; Ramio-Torrenta, L; Rodríguez-Antiguedad, A; Saiz, A; Tintore, M; Montalban-Gairin, X (ELSEVIER ESPANA SLU, 2022-10)
    INTRODUCTION: Alemtuzumab is a highly effective drug approved by the European Medicines Agency as a disease-modifying drug for the treatment of relapsing-remitting multiple sclerosis. OBJECTIVE: A consensus document was ...
  • Recommendations for vaccination in patients with multiple sclerosis who are eligible for immunosuppressive therapies: Spanish consensus statement 
    Otero-Romero, S; Rodríguez-García, J; Vilella, A; Ara, J-R; Brieva, L; Calles, C; Carmona, O; Casanova, V; Costa-Frossard, L; Eichau, S; García-Merino, J-A; García-Vidal, C; González-Platas, M; Llaneza, M; Martínez-Gines, M; Meca-Lallana, J-E; Prieto, J-M; Rodríguez-Antiguedad, A; Tintore, M; Blanco, Y; Moral, E (ELSEVIER ESPANA SLU, 2021-01)
    BACKGROUND: The recent development of highly effective treatments for multiple sclerosis (MS) and the potential risk of infectious complications require the development of prevention and risk minimisation strategies. ...
  • Will neurological care change over the next 5 years due to the COVID-19 pandemic? Key informant consensus survey 
    Matias-Guiu, J; Matias-Guiu, J-A; Álvarez-Sabin, J; Ramon-Ara, J; Arenillas, J; Casado-Naranjo, I; Castellanos, M; Jiménez-Hernández, M-D; Lainez-Andres, J-M; Moral, E; Morales, A; Rodríguez-Antiguedad, A; Segura, T; Serrano-Castro, P; Diez-Tejedor, E (ELSEVIER ESPANA SLU, 2020-04)
    INTRODUCTION: The COVID-19 pandemic will give rise to long-term changes in neurological care, which are not easily predictable. MATERIAL AND METHODS: A key informant survey was used to enquire about the changes expected ...